Namik Kirlic
Associate Investigator
Data updated
Research Footprint
Namik Kirlic appears in 6 tracked papers (2023–2026), most studied alongside Psilocybin, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Anxiety Disorders.
Most-cited paper: The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression (34 citations).
Frequent co-authors: Guy Goodwin, Ekaterina Malievskaia and Nadav Liam Modlin.
Background & Research
Dr. Namik Kirlic is a clinical psychologist and neuroscientist whose work spans threat processing, early-life adversity, and treatment response in mood and anxiety disorders. He returned to Tulsa for postdoctoral training at the Laureate Institute for Brain Research and became an Associate Investigator there in 2019, with research now including psychedelic treatment support and outcomes.
Key Impact
Clinical psychologist and neuroscientist notable for psychopharmacology and psychedelic-therapy research, including multiple psilocybin studies in depression and PTSD.
Collaboration Network
24 collaborators· click a node to visit their profile
Full network →